Bipolar mapping of intracardiac potentials with electrode having blood permeable covering

• US 6,408,199 B1
• Filed: 07/07/2000
• Issued: 06/18/2002
• Est. Priority Date: 07/07/2000
• Status: Expired due to Term

• Current Assignee: Biosense, Inc. (Cardinal Health, Inc.)
• Original Assignee: Biosense, Inc. (Cardinal Health, Inc.)
• Inventors: Goldin, Alexander
• Primary Examiner(s): Schaetzle, Kennedy
• Assistant Examiner(s): DROESCH, KRISTEN L
• Application Number:
  US09/612,490
• Time in Patent Office: 711 Days
• Field of Search: 600/372-374, 600/508, 600/509, 600/515, 600/518, 600/547, 128/901, 607/13, 607/115, 607/116, 607/119, 607/121, 607/122, 607/123
• US Class Current: 600/374
• CPC Class Codes: A61B 18/1492 having a flexible, catheter-like structure, e.g. for heart ablation A61B18/1477 takes precedence
• CPC Class Codes: A61B 2018/00065 porous
• CPC Class Codes: A61B 2034/2051 Electromagnetic tracking systems

Abstract

A method for measuring near-field electrical activity at a location in a heart comprising introducing into the heart a catheter. The catheter comprises an elongated tubular body having a distal region and a circumferential recess along the length of the distal region, a first electrode mounted on the distal region in close proximity to the circumferential recess, and a second electrode mounted within the circumferential recess. The distal region is positioned at the location in the heart so that the first electrode is in direct contact with heart tissue and the second electrode is not in direct contact with heart tissue but is in contact with blood. A first signal is obtained with the first electrode, and a second signal is obtained with the second electrode. The first signal and the second signal are compared to obtain the near-field electrical activity at the location in the heart.

Claims

1. A system for determining an arrhythmiogenic focus in heart tissue comprising:

a catheter comprising;

(i) an elongated body having a distal region;

(ii) a first electrode mounted on the distal region for obtaining a first signal;

(iii) a second electrode mounted on the distal region in close proximity to and electrically isolated from the first electrode for obtaining a second signal, the second electrode being covered by a blood-permeable membrane that, in use, prohibits direct contact between the second electrode and surrounding heart tissue; and

a signal processing unit operatively connected to the catheter for comparing the first signal and the second signal and subtracting far-field activity from the first signal for obtaining near-field electrical activity and identifying a location of an arrhythmiogenic focus based on near-field electrical activity.

2. A system as claimed in claim 1, wherein the blood permeable membrane of the catheter comprises a biocompatible composition.

3. A system as claimed in claim 1, wherein the first electrode of the catheter is a ring electrode.

4. A system as claimed in claim 1, wherein the first electrode of the catheter is a tip electrode.

5. A system as claimed in claim 1, wherein the catheter further comprises a location sensor.

6. A system as claimed in claim 5, wherein the location sensor of the catheter is an electromagnetic location sensor.

7. A method for determining an arrhythmiogenic focus at a location in a heart comprising:

introducing into the heart a catheter comprising;

an elongated body having a distal region,

a first electrode mounted on the distal region, and

a second electrode mounted on the distal region in close proximity to and electrically isolated from the first electrode, the second electrode being covered by a blood-permeable membrane that prohibits direct contact between the second electrode and surrounding heart tissue;

positioning the distal region at the location in the heart so that the first electrode is in direct contact with heart tissue and the second electrode is not in direct contact with heart tissue but is in contact with blood;

obtaining a first signal with the first electrode;

obtaining a second signal with the second electrode;

comparing the first signal and the second signal and subtracting far-field electrical activity from the first signal to obtain near-field electrical activity at the location in the heart; and

identifying the location of the arrhythmiogenic focus based on near-field electrical activity.

8. A method as claimed in claim 7, wherein the blood permeable membrane comprises a biocompatible composition.

9. A method as claimed in claim 7, wherein the first electrode is a ring electrode.

10. A method as claimed in claim 7, wherein the first electrode is a tip electrode.

11. A method as claimed in claim 7, wherein the catheter further comprises a location sensor.

12. A method as claimed in claim 11, wherein the location sensor is an electromagnetic location sensor.

13. A method as claimed in claim 11, further comprising acquiring near-field electrical activity information with the first and second electrodes and location information with the location sensor at a plurality of locations within the heart.

14. A method as claimed in claim 13, further comprising generating a map of the electrical activity of the heart using the acquired near-field electrical activity information and location information.